180 related articles for article (PubMed ID: 32039412)
1. NIR-cleavable drug adducts of gold nanostars for overcoming multidrug-resistant tumors.
Del Valle AC; Su CK; Sun YC; Huang YF
Biomater Sci; 2020 Mar; 8(7):1934-1950. PubMed ID: 32039412
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy and cardioprotection of nucleolin-targeted doxorubicin-loaded ultrasound nanobubbles in treating triple-negative breast cancer.
Fang K; Wang L; Huang H; Dong S; Guo Y
Nanotechnology; 2021 Mar; 32(24):. PubMed ID: 33690196
[TBL] [Abstract][Full Text] [Related]
3. Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment.
Liang X; Wang Y; Shi H; Dong M; Han H; Li Q
Int J Nanomedicine; 2021; 16():2569-2584. PubMed ID: 33833512
[TBL] [Abstract][Full Text] [Related]
4. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance.
Liao ZX; Chuang EY; Lin CC; Ho YC; Lin KJ; Cheng PY; Chen KJ; Wei HJ; Sung HW
J Control Release; 2015 Jun; 208():42-51. PubMed ID: 25637705
[TBL] [Abstract][Full Text] [Related]
5. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
Baneshi M; Dadfarnia S; Shabani AMH; Sabbagh SK; Haghgoo S; Bardania H
Int J Pharm; 2019 Jun; 564():145-152. PubMed ID: 30978484
[TBL] [Abstract][Full Text] [Related]
6. Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types.
Dam DH; Culver KS; Odom TW
Mol Pharm; 2014 Feb; 11(2):580-7. PubMed ID: 24422969
[TBL] [Abstract][Full Text] [Related]
7. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy.
Miao D; Yu Y; Chen Y; Liu Y; Su G
Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274
[TBL] [Abstract][Full Text] [Related]
8. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
[TBL] [Abstract][Full Text] [Related]
9. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
10. A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy.
Trinh TL; Zhu G; Xiao X; Puszyk W; Sefah K; Wu Q; Tan W; Liu C
PLoS One; 2015; 10(11):e0136673. PubMed ID: 26523833
[TBL] [Abstract][Full Text] [Related]
11. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
Shiao YS; Chiu HH; Wu PH; Huang YF
ACS Appl Mater Interfaces; 2014 Dec; 6(24):21832-41. PubMed ID: 24949657
[TBL] [Abstract][Full Text] [Related]
12. pH and near-infrared light dual-stimuli responsive drug delivery using DNA-conjugated gold nanorods for effective treatment of multidrug resistant cancer cells.
Zhang W; Wang F; Wang Y; Wang J; Yu Y; Guo S; Chen R; Zhou D
J Control Release; 2016 Jun; 232():9-19. PubMed ID: 27072026
[TBL] [Abstract][Full Text] [Related]
13. NIR-II light triggered nitric oxide release nanoplatform combined chemo-photothermal therapy for overcoming multidrug resistant cancer.
Wang J; Wu C; Qin X; Huang Y; Zhang J; Chen T; Wang Y; Ding Y; Yao Y
J Mater Chem B; 2021 Feb; 9(6):1698-1706. PubMed ID: 33495772
[TBL] [Abstract][Full Text] [Related]
14. Targeted co-delivery of FOXM1 aptamer and DOX by nucleolin aptamer-functionalized pH-responsive biocompatible nanodelivery system to enhance therapeutic efficacy against breast cancer: in vitro and in vivo.
Masoudi M; Taghdisi SM; Hashemitabar G; Abnous K
Drug Deliv Transl Res; 2024 Jun; 14(6):1535-1550. PubMed ID: 38161196
[TBL] [Abstract][Full Text] [Related]
15. A new NIR-triggered doxorubicin and photosensitizer indocyanine green co-delivery system for enhanced multidrug resistant cancer treatment through simultaneous chemo/photothermal/photodynamic therapy.
Yu Y; Zhang Z; Wang Y; Zhu H; Li F; Shen Y; Guo S
Acta Biomater; 2017 Sep; 59():170-180. PubMed ID: 28629893
[TBL] [Abstract][Full Text] [Related]
16. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles.
Mehrnia SS; Hashemi B; Mowla SJ; Nikkhah M; Arbabi A
Radiat Oncol; 2021 Feb; 16(1):33. PubMed ID: 33568174
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
Khademi Z; Lavaee P; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Carbohydr Polym; 2020 Nov; 248():116735. PubMed ID: 32919550
[TBL] [Abstract][Full Text] [Related]
19. Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells.
Zhang Z; Xu S; Wang Y; Yu Y; Li F; Zhu H; Shen Y; Huang S; Guo S
J Colloid Interface Sci; 2018 Jan; 509():47-57. PubMed ID: 28881205
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
